XML 20 R3.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 480,684 $ 437,722
Marketable securities (amortized cost of [in-cell link] and [in-cell link] at [in-cell link] and [in-cell link], respectively) 287,802 337,673
Accounts receivable, net of allowance for credit losses of [in-cell link] and [in-cell link] at [in-cell link] and [in-cell link], respectively 287,805 246,472
Contract cost asset, current 55,384 33,922
Prepaid expenses and other current assets 55,157 44,090
Total current assets 1,166,832 1,099,879
Marketable securities, non-current (amortized cost of [in-cell link] and [in-cell link] at [in-cell link] and [in-cell link], respectively) 42,529 46,042
Capitalized software development costs, net 142,228 112,321
Property and equipment, net 48,624 43,592
Right of use assets - finance leases 19,619 31,727
Right of use assets - operating leases 36,024 28,790
Contract cost asset, non-current 79,004 47,505
Intangible assets, net 105,364 120,946
Goodwill 574,083 549,651
Other assets 24,758 20,918
Total assets 2,239,065 2,101,371
Current liabilities    
Accounts payable 25,168 33,146
Accrued expenses 130,280 88,740
Deferred revenue, current 687,062 584,719
Other current liabilities 42,047 21,427
Total current liabilities 884,557 728,032
Deferred revenue, non-current 6,041 5,815
Finance lease liabilities, non-current 26,557 41,352
Operating lease liabilities, non-current 45,855 32,697
Other liabilities, non-current 13,793 5,122
Total liabilities 976,803 813,018
Commitments and contingencies (Note 11)
Stockholders’ equity    
Preferred stock, $0.0001 par value, 100,000,000 shares authorized at [in-cell link] and [in-cell link]; [in-cell link] shares issued and outstanding at [in-cell link] and [in-cell link]. 0 0
Common stock, $0.0001 par value, 1,000,000,000 shares authorized at [in-cell link] and [in-cell link] ; [in-cell link] and [in-cell link] shares issued and outstanding at [in-cell link] and [in-cell link], respectively. 15 15
Additional paid-in capital 2,609,093 2,535,868
Accumulated other comprehensive loss (1,270) (2,737)
Accumulated deficit (1,345,576) (1,244,793)
Total stockholders’ equity 1,262,262 1,288,353
Total liabilities and stockholders’ equity $ 2,239,065 $ 2,101,371